Amarin Corp Plc (AMRN)

[sstyles]

AMRN has stepped up direct to consumer marketing significantly. Vascepa ads have been appearing approximately 10x a day on various networks.

Either the company does not have a problem building the market for generics upon an appeal loss or something is giving the company a lot of confidence to go this strong out the gate.

Recall on April 30th, the Company said it will wait on DTC ads until the outcome of the appeal. This is what JT said on April 30th:

"In particular, we intend to defer most or all of our planned television campaign because it is expensive and most of its value in providing education on the cardiovascular risk reduction effects of VASCEPA are likely not to be near-term. Such campaign will be readied for launch when and if we are successful in the appeal of the ANDA litigation assuming patients have resumed regular visits to their physicians by that time."

On June 1st AMRN reversed course. I wonder what changed in those 30 days.

Time will tell....but from the amount of times the ads are running it seems AMRN no longer has a concern about building the market for generics.

The ads are appearing and they are running quite a bit on TV.